Disease: Hepatitis D
- A regular screening for hepatitis delta virus among chronic hepatitis B carriers improves the diagnostic of this infection and of subsequent cirrhosis development
- A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer
- Addendum „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS
- Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
- Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies
- An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis
- Antiviral Therapy of Chronic Hepatitis D Virus Infection - Addendum to the S3 Guideline "Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection" of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
- Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia
- Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies
- Bulevirtide and emerging drugs for the treatment of hepatitis D
- Bulevirtide for Chronic Hepatitis D
- Bulevirtide for Chronic Hepatitis D. Reply
- Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma
- Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
- Comparative analysis of human, rodent and snake deltavirus replication
- Comparative effectiveness of seven interventions for chronic hepatitis D: a systematic review and network meta-analysis of randomized controlled trials
- CRISPR/Cas13a-Assisted accurate and portable hepatitis D virus RNA detection
- Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections
- Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice
- Delta hepatitis in Africa: epidemiological and clinical particularities
- Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort
- Diagnosis and treatment of viral hepatitis B and D in 2024
- Difficulties in assessing portal hypertension in case of HVB-HVD co infection
- Dismantling Barriers to Hepatitis B and Delta Screening, Prevention, and Linkage to Care among the PWUD Community in Philadelphia
- Does hepatitis delta virus have a preference for hepatitis B virus genotype? A systematic review of the literature
- Editorial: Liver elastography for chronic hepatitis D-the end of liver biopsy?
- Editorial: The current challenges underlying hepatitis D virus infection
- Efficacy of Newer Nucleos(t)ide Analogs After Hepatitis B Immunoglobulin Discontinuation Against Hepatitis B and D Recurrence in Liver Transplant Recipients
- Enrichment reveals extensive integration of hepatitis B virus DNA in hepatitis delta-infected patients
- Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?
- Ergosterol peroxide blocks HDV infection as a novel entry inhibitor by targeting human NTCP receptor
- Estimating the prevalence of hepatitis delta virus infection among adults in the United States: A meta-analysis
- Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns
- Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D
- Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus in Utah 2000-2021
- Hepatitis B in Pediatric Population: Observational Retrospective Study in Romania
- Hepatitis B Vaccine: Four Decades on
- Hepatitis D infection induces IFN-beta-mediated NK cell activation and TRAIL-dependent cytotoxicity
- Hepatitis D infection induces IFN-β-mediated NK cell activation and TRAIL-dependent cytotoxicity
- Hepatitis D Virus and HBsAg Dynamics in the era of new Antiviral Treatments
- Hepatitis D virus dual-infection among Chinese hepatitis B patient related to hepatitis B surface antigen, hepatitis B virus DNA and age
- Hepatitis D Virus Infection
- Hepatitis D Virus Infection. Reply
- Hepatitis D virus reactivation in liver-transplanted patients receiving hepatitis B immunoglobulin
- Hepatitis D: a neglected aspect of elimination efforts
- Hepatitis D: A Review
- Hepatitis delta testing trends in a US national cohort: An analysis of patient and provider-level predictive factors
- Hepatitis Delta Virus Reporting Requirements in the United States and Territories: A Systematic Review
- HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression
- ICTV Virus Taxonomy Profile: <em>Kolmioviridae</em> 2024
- Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma
- Impact of anti-HDV reflex testing at HBs antigen positive discovery in a single center France: Support for primary HDV screening in France
- Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis
- Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies
- Independent predictors for non-alcoholic fatty liver disease in patients with treatment-naïve chronic hepatitis B
- Inhibition of cellular factor TM6SF2 suppresses secretion pathways of Hepatitis B, Hepatitis C and Hepatitis D viruses
- Is there a need for universal double reflex testing of HBsAg-positive individuals for hepatitis D infection?
- JAK1 promotes HDV replication and is a potential target for antiviral therapy
- Leitlinienreport des Addendums „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwe
- Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
- Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D-Authors' reply
- Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
- Liver transplantation in viral and autoimmune liver diseases
- Long-Term Strategies for Poorly Water-Soluble Peptides: Combining Fatty Acid Modification with PAS Fusion
- Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop
- Management of chronic HBV-HDV patients chronic HBV-HDV infection: A review on new management options
- Maternal-to-Child Transmission of Hepatitis B Virus and Hepatitis Delta Virus
- Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
- Molecular determinants within the C-termini of L-HDAg that regulate hepatitis D virus replication and assembly
- Non-Invasive Prediction Scores for Hepatitis B Virus- and Hepatitis D Virus-Infected Patients-A Cohort from the North-Eastern Part of Romania
- Omicron breakthrough infections in vaccinated or previously infected hamsters
- Opt-out testing for hepatitis B and C infections in adults attending the emergency department of a large London teaching hospital
- Pharmacist-led patient education improves medication self-management and adherence in chronic hepatitis D virus patients: insights from the EXPLAIN project
- Point-of-Care Testing for Hepatitis Viruses: A Growing Need
- Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication
- Prevalence of hepatitis B virus infection among general population of Armenia in 2021 and factors associated with it: a cross-sectional study
- Prevalence of hepatitis D virus infection among patients with chronic hepatitis B infection in a tertiary care centre in Thailand
- Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication
- Prospective study of hepatitis B and D epidemiology and risk factors in Romania: A 10-year update
- Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods
- Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea
- Recent treatment advances and practical management of hepatitis D virus
- Results of Response-Guided Therapy with Pegylated Interferon Alpha 2a in Chronic Hepatitis B and D
- Risk factors associated with hepatitis D virus infection and preventive strategies in Mongolia
- Safety and efficacy of off-label bulevirtide monotherapy in HDV patients with decompensated Child-B cirrhosis - a real world case series
- Salivary Glands and Viral Pathogenesis
- State of the Art: Test all for Anti-Hepatitis D Virus and Reflex to Hepatitis D Virus RNA Polymerase Chain Reaction Quantification
- Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP
- Systemic cytokine and viral antigen-specific responses in hepatitis D virus RNA positive versus HDV RNA negative patients
- The adjusted prevalence of hepatitis delta virus (HDV) in 25 countries and territories
- The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 years
- The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection
- The elimination of hepatitis D as a public health problem: Needs and challenges
- The Forgotten Virus, Hepatitis D: A Review of Epidemiology, Diagnosis, and Current Treatment Strategies
- Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies
- Unmet need in screening for hepatitis D virus: time to take action
- Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta
- What Is Hepatitis D Infection?
- What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New Options
- What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?